VanEck Pharmaceutical ETF
PPH
PPH
139 hedge funds and large institutions have $511M invested in VanEck Pharmaceutical ETF in 2024 Q4 according to their latest regulatory filings, with 30 funds opening new positions, 45 increasing their positions, 41 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
1% less funds holding
Funds holding: 140 → 139 (-1)
6% less capital invested
Capital invested by funds: $544M → $511M (-$32.5M)
71% less call options, than puts
Call options by funds: $1.25M | Put options by funds: $4.37M
Holders
139
Holding in Top 10
1
Calls
$1.25M
Puts
$4.37M
Top Buyers
| 1 | +$16.8M | |
| 2 | +$16.7M | |
| 3 | +$15.6M | |
| 4 |
Two Sigma Investments
New York
|
+$12.5M |
| 5 |
FDCDDQ
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
|
+$11.4M |
Top Sellers
| 1 | -$23.6M | |
| 2 | -$13.8M | |
| 3 | -$8.82M | |
| 4 |
Thrivent Financial for Lutherans
Minneapolis,
Minnesota
|
-$7.06M |
| 5 |
BHB
Bank Hapoalim BM
Tel Aviv,
Israel
|
-$3.77M |